bioRxiv · 10.1101/2021.06.04.446996
DNA-PKcs kinase activity stabilizes the transcription factor Egr1 in activated immune cells
Abstract
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is known primarily for its function in DNA double-stranded break repair and non-homologous end joining (NHEJ). However, DNA-PKcs also has a critical yet undefined role in immunity impacting both myeloid and lymphoid cell lineages spurring interest in targeting DNA-PKcs for therapeutic strategies in immune-related diseases. To gain insight into the function of DNA-PKcs within immune cells, we performed a quantitative phosphoproteomic screen in T cells to identify first order phosphorylation targets of DNA-PKcs. Results indicate that DNA-PKcs phosphorylates the transcription factor Egr1 (early growth response protein 1) at S301. Expression of Egr1 is induced early upon T cell activation and dictates T cell response by modulating expression of cytokines and key costimulatory molecules. Mutation of serine 301 to alanine via CRISPR-Cas9 resulted in increased proteasomal degradation of Egr1 and a decrease in Egr1-dependent transcription of IL2 (interleukin-2) in activated T cells. Our findings identify DNA-PKcs as a critical intermediary link between T cell activation and T cell fate and a novel phosphosite involved in regulating Egr1 activity.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Waldrip, Z. J., Burdine, L., Harrison, D. K., Azevedo-Pouly, A. C., Storey, A. J., Moffett, O. G., Mackintosh, S. G., Burdine, M. S.. 2021-06-04. DNA-PKcs kinase activity stabilizes the transcription factor Egr1 in activated immune cells. https://doi.org/10.1101/2021.06.04.446996
Cite the original work for its findings. Save a collection to share your selection of sources.